More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article about Research That Could Be “Future New Wave of Medicine”

Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article about Research That Could Be “Future New Wave of Medicine”

by | Jul 15, 2016 | Kannalife Sciences, Press Releases

Article Highlights How Cannabinoid Research May Help in Future Treatment for NFL Players Suffering from Concussion-Related Disease CTE San Diego, CA – July 14, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that its portfolio company Kannalife Sciences,...
Medical Marijuana, Inc. CEO to Speak on Nutritional and Therapuetic Benefits of Hemp at 3rd Annual Cannabis World Congress and Business Expo

Medical Marijuana, Inc. CEO to Speak on Nutritional and Therapuetic Benefits of Hemp at 3rd Annual Cannabis World Congress and Business Expo

by | Jun 9, 2016 | Company News, Kannalife Sciences, Press Releases

RSHO Advocate Penny Howard to Share Story on How Her Fight to Save Daughter Harper Helped Legalize New Markets and Change Lives in Latin America SAN DIEGO, CA – June 9, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that at the 3rd Annual Cannabis World...
Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

by | Feb 22, 2016 | Company News, Kannalife Sciences, Press Releases

Kannalife Sciences, Inc., a Phyto-Medical Company™ has found through its research that KLS-13019 is 50x More Potent and Over 400-Fold Safer Than CBD SAN DIEGO, CA – February 18, 2016 – Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that the Company’s...

Subscribe for Company Updates

* indicates required

Follow us on

social networks

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.